Pentagon Defense Contracts Order $108 Million in Medical Supplies, Software

Before you go, we thought you'd like these...
Before you go close icon

The Department of Defense announced 51 defense contracts Monday, worth more than $2.14 billion combined. A significant number of the announced awards concerned the delivery of medical devices and supplies. Among them:

  • Abbott Laboratories was awarded the second of seven possible one-year option periods on a contract to supply various medical and surgical products to the U.S. Army, Navy, Air Force, Marine Corps, and federal civilian agencies. Valued at up to $45.3 million for just this one option year, this contract will now continue through at least Sept. 27, 2014.
  • Zimmer Holdings was awarded the first of seven possible one-year option periods on a similar contract to supply various medical and surgical products, also to the Army, Navy, Air Force, Marine Corps, and federal civilian agencies. This contract is valued at up to $36.9 million, and it will run through at least Sept. 26, 2014.
  • Johnson & Johnson subsidiary DePuy Orthopaedics won the second of seven one-year option periods on a contract to supply various medical and surgical products. Smaller in dollar value at just $18.9 million, J&J will be supplying the same customers, and its contract will run through at least Sept. 24, 2014.
  • Finally, a somewhat different award went to Cardinal Health . This one, worth up to $7.1 million, is for the second out of four potential option years, but it concerns not medical supplies but rather "the establishment of a license agreement for use of various software applications." Once again, though, the beneficiaries are Army, Navy, Air Force, Marine Corps, and federal civilian agencies. Completion date: Sept. 25, 2014. 

link

The article Pentagon Defense Contracts Order $108 Million in Medical Supplies, Software originally appeared on Fool.com.

Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson and Zimmer Holdings. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners